Cefprozil tab. dry syr.

Cefprozil tab. dry syr.
Product Description

Yungjin Pharma offers a range of products which includes cefprozil tab./dry syr. Active ingredient: Cefprozil. Efficacy & Effect: This drug is used to treat Staphylococcus aureus and Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Dosage: 500mg, 2 times daily after meals. Package: 250mg tab. X 30T, 100T. 5.0g(100g) X 60mL/bottle. Is is an Oral 2nd generation Cephalosporin antibiotics. Interferes with bacterial cell-wall synthesis and division by binding to cell wall, causing cell to die. Active against gram-negative and gram-positive bacteria, with expanded activity against gram-negative bacteria.

YUNGJIN PHARM. CO. LTD.

  • KR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Licensee
Manufacturer/Innovator

YUNGJIN PHARM. CO. LTD.

  • KR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 500 - 999
    Employees
Company types
Licensee
Manufacturer/Innovator

More Products from YUNGJIN PHARM. CO. LTD. (84)

  • Cefotaxime inj.

    Product Cefotaxime inj.

    Yungjin Pharma offers a range of products which includes cefotaxime inj. Active ingredient: Cefotaxime Sodium. Efficacy & Effects: Pneumonia, bronchitis, pyelonephritis, cystitis, urethritis, sepsis, bacterial endocarditis, osteomyelitis, peritonitis, gonorrhoea, intrauterine infection. Dosage: Adults: 1g~...
  • Cefotiam Hexetil

    Product Cefotiam Hexetil

    Yungjin Pharma offers a range of products which includes cefotiam hexetil. Specification: JP. Description: White to light yellow powder. Assay: 615 ~ 690 ?g/mg (as cefotiam and anhydrous basis). Packaging: 25 kg, Fiber drum. Prodrug of 2nd generation cephalosporin administered intramuscularly or intravenou...
  • Cefotiam Hydrochloride

    Product Cefotiam Hydrochloride

    Yungjin Pharma offers a range of products which includes cefotiam hydrochloride. Specification: JP, KP. Description: White to light yellow crystalline powder. Assay: 810 ~ 890 ?g/mg (as cefotiam and anhydrous basis). Packaging : 10 kg, Aluminium can. It is a 2nd generation Cephalosporin antibiotics. Inter...
  • Cefotiam inj.

    Product Cefotiam inj.

    Yungjin Pharma offers a range of products which includes cefotiam inj. Active ingredient: Cefotiam hydrochloride. Efficacy & Effects: Infection in burn and operative wound, subcutaneous abscess, osteomyelitis, purulent, bronchitis, bronchiectasis, pneumonia, lung abscess, thoracic empyema cholecystitis, ch...
  • Cefpirom inj.

    Product Cefpirom inj.

    Yungjin Pharma offers a range of products which includes cefpirom inj. Active ingredient: Cefpirom sulfate. Efficacy & Effect: Blood and tissues infenctions, kidney infections, lungs and airways infenctions urinasry system infections, skin or wound infections. Dosage: Adult: 1g~2g(potency)/12 hours. Packag...
  • Cefpodoxime Proxetil

    Product Cefpodoxime Proxetil

    Yungjin Pharma offers a range of products which includes cefpodoxime proxetil. Specification: JP. Description: White to light brownish white powder. Assay : 706 ~ 774 ?g/mg (as cefpodoxime and anhydrous basis). Packaging: 20 kg, Fiber drum. It is an Oral 3rd generation Cephalosporin antibiotics, Cefpodoxim...
  • Ceftazidime Hydrate

    Product Ceftazidime Hydrate

    Yungjin Pharma offers a range of products which includes ceftazidime hydrate. Specification: JP, KP. Description: White to light yellowish white crystalline powder. Assay: 950 ~ 1020 ?g/mg (as ceftazidime and dried basis). Packaging : 10 kg, Aluminium can. It is a 3rd generation Cephalosporin antibiotics. ...
  • Ceftazidime inj.

    Product Ceftazidime inj.

    Yungjin Pharma offers a range of products which includes ceftazidime inj. Active ingredient: Ceftazidime pentahydrate. Efficacy & Effect: Sepsis, meningitis, pneumonia, bronchopneumonia, thoracic empyema, lung abscess, bronchiectasis, bronchitis, prostatitis, cystitis, urethritis, skin ulcer, peritonitis...
  • Ceftizoxime Sodium

    Product Ceftizoxime Sodium

    Yungjin Pharma offers a range of products which includes ceftizoxime sodium. Specification: JP, KP, CP. Description: White to light yellow crystalline powder. Assay: Not less than 900 ?g/mg (as ceftizoxime and anhydrous basis). Packaging: 10 kg, Aluminium can. It is a 3rd generation Cephalosporin antibioti...
  • Ceftriaxone inj.

    Product Ceftriaxone inj.

    Yungjin Pharma offers a range of products which includes ceftriaxone inj. Active ingredient: Ceftriaxone sodium. Efficacy & Effect: Respiratory infections, renal & urinary tract infections, septicemia, meningitis, prevention of pre & post-operative infection, bone & joint infections, skin· wound & soft tis...
  • Cepoxetil tab.

    Product Cepoxetil tab.

    Yungjin Pharma offers a range of products which includes cepoxetil tab. Active ingredient: Cefpodoxime proxetil. Efficacy & Effect: Otitis media, pneumonia, laryngopharyngitis, tonsillitis, bronchitis, pyelonephritis, gonococcal urethritis, folliculitis, cellulitis, infected atheroma, subcutaneous abscess,...
  • Citalo tab.

    Product Citalo tab.

    Yungjin Pharma offers a range of products which includes citalo tab. Active Ingredient: Escitalopram. Efficacy & Effect: Escitalopram implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine s...

YUNGJIN PHARM. CO. LTD. resources (1)

  • Video OVERVIEW

    "Improvement of world health advances through Globalization and Partnerships"

    Company name : Yungjin Pharm. Co., Ltd
    CEO : Chae Joon, Lee
    Location : 13, Olympic-ro 35da-gil, Songpa-gu, Seoul, Korea
    Foundation date : October 10, 1952
    Representative products: Cephalosporin Antibiotic, Antipsychotic, Cardiovascular, Total Nutrition, and etc.


    Yungjin Pharm. Co., Ltd was established in 1952, has been playing a major role as a forerunner in the Korean pharmaceutical industry for half a century. With our inspiring mission statement, "To relieve the suffering of mankind from diseases with our innovative, effective and safe pharmaceutical products", we have shown our
    successful contribution not only within Korea, but also through global expansion. As a result, we have received a total of 25 awards including the President Award for Superior Product Development, the Prime Minister Award, Industry Award and many more. These accomplishments demonstrate our sustainability and commitment to the development of innovative products and business excellence in both overseas and domestic segments.